Table 4.

Transplant outcomes

Outcomes
Engraftment
Neutrophil engraftment, median (range), d	10 (8-20)
Platelet engraftment, median (range), d	18 (13-40)
Cumulative incidence of any GVHD at 1 y	65% (95% CI, 38-83)
PFS
PFS from second SCT, median (range), d	350 (38-859)
OS from second SCT, median (range), d	608 (38-919)
1-y PFS	55%
2-y PFS	48%
OS
1-y OS	60%
2-y OS	50%
Relapse
1-y cumulative incidence of relapse	28% (CI, 9-50)
2-y cumulative incidence of relapse	35% (CI, 13-58)
1-y NRM	17% (95% CI 4-39%)
2-y NRM	17% (95% CI 4-39%)
No. of patients with acute GVHD
Grade 1	0
Grade 2	8
Grade 3	3
Grade 4	0
No. of patients with chronic GVHD (mild/moderate/severe)
Mild	1
Moderate	1
Severe	2

CI, confidence interval.